| Thyroid hormones, oxidative stress, and inflammation A Mancini, C Di Segni, S Raimondo, G Olivieri, A Silvestrini, E Meucci, ... Mediators of inflammation 2016, 2016 | 450 | 2016 |
| Erosive arthritis in systemic lupus erythematosus: not only Rhupus F Ceccarelli, F Natalucci, G Olivieri, C Perricone, C Pirone, FR Spinelli, ... Lupus 30 (13), 2029-2041, 2021 | 21 | 2021 |
| Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype F Ceccarelli, C Perricone, G Olivieri, E Cipriano, FR Spinelli, G Valesini, ... International journal of molecular sciences 20 (22), 5624, 2019 | 19 | 2019 |
| Oxidative stress in adult growth hormone deficiency: different plasma antioxidant patterns in comparison with metabolic syndrome A Mancini, C Di Segni, C Bruno, G Olivieri, F Guidi, A Silvestrini, E Meucci, ... Endocrine 59, 130-136, 2018 | 15 | 2018 |
| Oxidative stress as a possible mechanism underlying multi-hormonal deficiency in chronic heart failure. A Mancini, E Vergani, C Bruno, G Olivieri, C Di Segni, A Silvestrini, ... European Review for Medical & Pharmacological Sciences 22 (12), 2018 | 14 | 2018 |
| Arthritis in systemic lupus erythematosus: from 2022 International GISEA/OEG symposium F Ceccarelli, M Govoni, M Piga, G Cassone, FP Cantatore, G Olivieri, ... Journal of clinical medicine 11 (20), 6016, 2022 | 11 | 2022 |
| Comprehensive disease control in systemic lupus erythematosus F Ceccarelli, G Olivieri, A Sortino, L Dominici, F Arefayne, AI Celia, ... Seminars in Arthritis and Rheumatism 51 (2), 404-408, 2021 | 10 | 2021 |
| Joint involvement influences quality of life in systemic lupus erythematosus patients F Natalucci, F Ceccarelli, E Cipriano, C Perricone, G Olivieri, C Pirone, ... Lupus 30 (3), 478-483, 2021 | 10 | 2021 |
| Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab I Schiavoni, E Olivetta, F Natalucci, G Olivieri, A Lo Presti, G Fedele, ... Lupus 32 (3), 394-400, 2023 | 7 | 2023 |
| Erosive arthritis in systemic lupus erythematosus: application of cluster analysis. F Ceccarelli, F Natalucci, C Pirone, G Olivieri, T Colasanti, L Picciariello, ... Clinical and Experimental Rheumatology, 2022 | 7 | 2022 |
| Can machine learning models support physicians in systemic lupus erythematosus diagnosis? Results from a monocentric cohort F Ceccarelli, M Lapucci, G Olivieri, A Sortino, F Natalucci, FR Spinelli, ... Joint Bone Spine 89 (3), 2022 | 7 | 2022 |
| Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients V Orefice, F Ceccarelli, C Barbati, R Lucchetti, G Olivieri, E Cipriano, ... Lupus 29 (11), 1377-1384, 2020 | 7 | 2020 |
| Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon F Ceccarelli, C Perricone, F Natalucci, L Picciariello, G Olivieri, G Cafaro, ... Autoimmunity Reviews, 103374, 2023 | 5 | 2023 |
| Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus: Comparison between renal and non-renal involvement G Olivieri, F Ceccarelli, F Natalucci, C Pirone, V Orefice, VA Pacucci, ... Joint Bone Spine 88 (6), 105246, 2021 | 5 | 2021 |
| Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study. F Ceccarelli, E Cipriano, F Natalucci, C Perricone, G Olivieri, V Orefice, ... The Israel Medical Association Journal: IMAJ 22 (7), 415-419, 2020 | 5 | 2020 |
| The impacts of the clinical and genetic factors on chronic damage in Caucasian systemic lupus erythematosus patients F Ceccarelli, G Olivieri, C Pirone, C Ciccacci, L Picciariello, F Natalucci, ... Journal of Clinical Medicine 11 (12), 3368, 2022 | 4 | 2022 |
| Systemic lupus erythematosus before and after COVID-19 lockdown: how the perception of disease changes through the lenses of narrative medicine F Ceccarelli, V Covelli, G Olivieri, F Natalucci, F Conti Healthcare 9 (6), 726, 2021 | 4 | 2021 |
| Rheumatic diseases development in patients treated by anti-PD1 immune checkpoint inhibitors: A single-centre descriptive study F Ceccarelli, F Natalucci, L Picciariello, G Olivieri, A Cirillo, A Gelibter, ... Life 13 (4), 877, 2023 | 3 | 2023 |
| How CD4+ T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation Assays GR Pascucci, E Morrocchi, C Pighi, A Rotili, A Neri, C Medri, G Olivieri, ... Biomedicines 11 (3), 888, 2023 | 2 | 2023 |
| Science and visual Arts: Binomial or Dichotomy? A Pilot study in Systemic Lupus Erythematosus patients V Ferrara, ME Perrone, C Mina, F Ceccarelli, G Olivieri, F Fattapposta, ... Lupus 31 (14), 1744-1749, 2022 | 2 | 2022 |
